• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[所谓的尿毒症性心脏病]

[So-called uremic heart diseases].

作者信息

Grollier G, Hurault de Ligny B, Bonnet H, Scanu P, Potier J C

机构信息

Service de soins intensifs de cardiologie, CHU Côte de Nacre, Caen.

出版信息

Arch Mal Coeur Vaiss. 1990 Mar;83(3):401-6.

PMID:2108635
Abstract

The overall cardiovascular mortality in patients with chronic renal failure is about 30 per cent of which 10 per cent is attributed to myocardial infarction. This prevalence led some workers to propose a hypothesis of "accelerated atherosclerosis" due to the hyperlipidaemia observed in 30 to 70 per cent of patients. However, the concept of accelerated atherosclerosis, which was based essentially on clinical studies, has been questioned. Pericardial effusion is a common complication of chronic renal failure and has been reported in over 62 per cent of patients in echocardiographic studies. There are many causes and symptoms are often mild; systematic echocardiographic examination of patients with renal failure undergoing haemodialysis has shown 32 per cent of pericardial effusions to be asymptomatic. There are two potential complications: cardiac tamponade and, lesser frequently, constrictive pericarditis. Cardiac failure is a common cause of death in patients undergoing long-term dialysis. The myocardial histological appearances are those of fibrosis, the etiology of which is not fully understood although the dialysis membranes and hypotensive episodes occurring during haemodialysis have been thought to play a role. Left ventricular hypertrophy and fibrosis may give rise to ventricular arrhythmias which could explain some of the cases of sudden death observed in patients with renal failure and often wrongly attributed to ischemic heart disease. Another form of myocardial disease which is observed later is characterised by an alteration of systolic function with left ventricular dilatation and hypokinesia and increased end diastolic pressures without an increase in left ventricular wall thickness. Valvular heart disease may also result from renal failure.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

慢性肾衰竭患者的总体心血管死亡率约为30%,其中10%归因于心肌梗死。这种患病率促使一些研究者提出了“加速动脉粥样硬化”假说,这是由于在30%至70%的患者中观察到了高脂血症。然而,主要基于临床研究的加速动脉粥样硬化这一概念受到了质疑。心包积液是慢性肾衰竭的常见并发症,在超声心动图研究中,超过62%的患者有此情况报告。其病因众多,症状通常较轻;对接受血液透析的肾衰竭患者进行的系统性超声心动图检查显示,32%的心包积液无症状。有两种潜在并发症:心脏压塞,较少见的是缩窄性心包炎。心力衰竭是长期透析患者常见的死亡原因。心肌组织学表现为纤维化,其病因尚未完全明确,不过血液透析过程中使用的透析膜和低血压发作被认为起到了一定作用。左心室肥厚和纤维化可能引发室性心律失常,这可以解释肾衰竭患者中观察到的一些猝死病例,这些病例常常被错误地归因于缺血性心脏病。后来观察到的另一种心肌疾病形式其特征为收缩功能改变,伴有左心室扩张、运动减弱以及舒张末期压力升高,而左心室壁厚度并未增加。肾衰竭也可能导致心脏瓣膜病。(摘要截选至250词)

相似文献

1
[So-called uremic heart diseases].[所谓的尿毒症性心脏病]
Arch Mal Coeur Vaiss. 1990 Mar;83(3):401-6.
2
Heart failure in patients with chronic kidney disease.慢性肾病患者的心力衰竭
Rocz Akad Med Bialymst. 2004;49:162-5.
3
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
4
Occlusive arterial disease in uraemic and haemodialysis patients and renal transplant recipients. A study of the incidence of arterial disease and of the prevalence of risk factors implicated in the pathogenesis of arteriosclerosis.尿毒症患者、血液透析患者及肾移植受者的闭塞性动脉疾病。一项关于动脉疾病发病率及动脉粥样硬化发病机制中相关危险因素患病率的研究。
Q J Med. 1977 Apr;46(182):197-214.
5
[Cardiovascular repercussions of chronic hemodialysis].[慢性血液透析的心血管影响]
Rev Prat. 1990 Mar 1;40(7):625-9.
6
[Conditions and consequences of cardiac alterations in patients with end-stage renal disease on maintenance hemodialysis].[维持性血液透析的终末期肾病患者心脏改变的情况及后果]
Postepy Hig Med Dosw. 1996;50(3):277-91.
7
Pericarditis in end-stage renal disease.终末期肾病中的心包炎
Cardiol Clin. 1990 Nov;8(4):701-7.
8
[Brain natriuretic peptide (BNP) and N-terminal-pro BNP in chronic haemodialysed renal failure].[慢性血液透析肾衰竭患者中的脑钠肽(BNP)和N末端脑钠肽前体]
Arch Mal Coeur Vaiss. 2004 Sep;97(9):881-8.
9
Cardiac consequences of hypertension in hemodialysis patients.血液透析患者高血压的心脏后果
Semin Dial. 2004 Jul-Aug;17(4):299-303. doi: 10.1111/j.0894-0959.2004.17331.x.
10
Cardiovascular disease in uremic patients on hemodialysis.血液透析的尿毒症患者的心血管疾病
Kidney Int Suppl. 1975 Jan(2):167-75.

引用本文的文献

1
Uraemic Cardiomyopathy: A Review of Current Literature.尿毒症心肌病:当前文献综述
Clin Med Insights Cardiol. 2021 Feb 23;15:1179546821998347. doi: 10.1177/1179546821998347. eCollection 2021.
2
Uremic Cardiomyopathy: A New Piece in the Chronic Kidney Disease-Mineral and Bone Disorder Puzzle.尿毒症心肌病:慢性肾脏病-矿物质和骨代谢紊乱难题中的新拼图。
Front Med (Lausanne). 2018 Jul 24;5:206. doi: 10.3389/fmed.2018.00206. eCollection 2018.